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Abstract
Background
Failure to detect psychiatric patients’ intellectual disabilities may lead to inappropriate treat-
ment and greater use of coercive measures.
Aims
In this prospective dynamic cohort study we screened for intellectual disabilities in patients
admitted to psychiatric wards, and investigated the use of coercive measures with these
patients.
Methods
We used the Screener for Intelligence and Learning disabilities (SCIL) to screen patients
admitted to two acute psychiatric wards, and assessed patient characteristics and coercive
measures during their stay and over the last 5 years.
Results
Results on the SCIL suggested that 43.8% of the sample had Mild Intellectual Disability or
Borderline Intellectual Functioning (MID/BIF). During their current stay and earlier stays in
the previous 5 years, these patients had an increased risk of involuntary admission (OR
2.71; SD 1.28–5.70) and coercive measures (OR 3.95, SD 1.47–10.54).
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Conclusions
This study suggests that functioning on the level of MID/BIF is very prevalent in admitted
psychiatric patients and requires specific attention from mental health care staff.
Introduction
Many individuals with Mild Intellectual Disability and Borderline Intellectual Functioning
(MID/BIF; IQ between 50 and 84) have difficulties in society and may also have problems with
adaptive behavior [1,2]. Mild Intellectual Disability (MID; IQ between 50 and 70) is generally
detected early in life, unlike Borderline Intellectual Functioning (BIF; IQ between 70–85), which is
more often unknown to an individual, his/her family, or others[3]. Thirty-one percent of adoles-
cents with BIF have been estimated to have poor social functioning, as well as other problems[4].
According to the definitions and methods used, estimates of the prevalence of MID/BIF in
the general population vary greatly. In Western countries, the population prevalence of Mild
Intellectual Disabilities (MID) is estimated to be 0.7–1.3% [5, 6]. On the basis of the normal
distribution of intelligence in the general population, 2.14% would have a IQ in the 50–70
range (MID) and 13.59% in the 71–84 range (BIF).
The prevalence of MID/BIF does not seem to have been studied extensively in psychiatric
adult patients, with the exception of some studies in MID patients [7, 8] or BIF patients [9], it
is thus unknown in people with severe mental illness treated in inpatient and outpatient set-
tings, and often seems to go unrecognized [9, 10]. Such unawareness is likely to result in inade-
quate treatment, more lengthy hospital stays, more use of coercive measures, and poor
outcome [8, 11]. Due to patients’ lack of ability to verbalize their feelings and emotions, the dif-
ficulties they experience may be expressed more often in acting-out behavior and somatic
complaints. These can be wrongly interpreted, leading to false diagnosis and treatment [8].
There are various special considerations which have to be taken into account in assessing and
classifying psychiatric disorders in adults with MID, including among others associations
between comorbid conditions and a patient’s communicative limitations; a patient’s impaired
capacity for providing consent; an assessor’s response style; and an assessor’s use of informa-
tion from multiple sources [12].
Although it is not known why MID/BIF is poorly recognized, it is probably due to problems
in communication, such as verbal handicaps and a poor vocabulary. It may also be due partly
to “streetwise” presentation on the part of various individuals, or to socially acceptable answers
that conceal intellectual shortcomings[1]. The clinical presentation of symptoms in patients
with MID/BIF may also differ from that in patients with a normal IQ.
If clinicians knew the prevalence of MID/BIF in everyday psychiatric practice, they might
be aware of the need to diagnose it and to take account of any intellectual disabilities in their
patients. However, validated tests for assessing IQ are time consuming—a problem that led to
the development of the Screener for Intelligence and Learning disabilities (SCIL), a short
14-item questionnaire that provides global insight into a patient’s cognitive abilities and
assesses the risk for MID/BIF.
In this study we therefore determined the percentage of patients suspected of having a
MID/BIF according to the SCIL in patients admitted to two wards for acute psychiatry in two
different general hospitals. Second, we checked whether MID/BIF was documented in medical
charts. Third, we compared the demographic and psychiatric characteristics of the SCIL-posi-
tive and the SCIL-negative patients. Finally, we investigated the number of involuntary admis-
sions and coercive measures in the SCIL-positive and the SCIL-negative patients.
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Methods
Design and setting
This prospective dynamic cohort study involved patients admitted to two acute psychiatric
wards in general hospitals located in a catchment area with 300,000 inhabitants in the eastern
Netherlands. The study was conducted and reported in accordance with the STROBE guide-
lines for reporting observational studies[13].
MID/BIF screening using the SCIL
A test consisting of 14 questions and minor tasks, the SCIL is intended to provide global
insight into a patient’s cognitive abilities. It was developed specifically to detect MID/BIF (IQ
50–84) in people in various social-service and health-care settings, and in jails, police stations,
and homeless settings. It was validated in an adult sample consisting of 318 participants from
social workplaces, probation services, organizations that provide support to clients with (intel-
lectual) disabilities living in the community, and also treatment facilities for addiction care
and mental health problems, by comparing the scores on the SCIL with test results obtained
on the WAIS III [14–16]. The reliability of the SCIL expressed in Cronbach’s alpha was good
(0.83 in the sample of 318 adult subjects). The AUC- value was high (0.93 in the adult sample).
With 19 or lower as cut-off score, the SCIL accurately classified 82% of people with MID/BIF.
Similarly, about 9 out of 10 people without MID/BIF (89%) were correctly classified as having
no MID/BIF [15, 16].
The SCIL identifies two categories: SCIL positive, i.e., patients with a high risk of having
MID/BIF; and SCIL negative, i.e., those patients with a low risk. No specific professional
degree is required to administer the SCIL. Before administering it, the nurses who participated
in the current study received two hours of training, after which they first assessed 8 patients
under supervision before performing assessments on their own.
Patients
All patients admitted for more than 6 days between June 15, 2014 and June, 14 2015 were eligi-
ble for the study. The SCIL was administered by nurses who were not involved in treating
these patients. The exclusion criteria were a patient’s lack of command of Dutch, or his or her
lack of cooperation. To engage in the test, patients also had to be able to concentrate for at
least 20 minutes, an ability that was determined by the nurses. If the patient showed acute psy-
chotic or an otherwise severely disordered mental state, the SCIL was not administered until
recovery allowed the patient to concentrate.
Chart information
The following was extracted from digital medical charts: basic demographic data, such as age,
gender, marital status, ethnic background, and psychiatric diagnosis (DSM-IV-TR, as assessed
by the psychiatrist on the ward); and information on admission history, previous voluntary or
involuntary admissions, and current or previous coercion. The medical charts were also read
by a research assistant (a psychologist). For the latter there were three reasons: to confirm the
information in question, to screen for any IQ data, and to screen the biography for any infor-
mation on MID/BIF such as diplomas and broken school careers.
Coercive measures
Coercive measures were rated prospectively during the current hospital stay by means of the
Argus rating scale [17], a short instrument covering all coercive measures such as seclusion,
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restraint and enforced medication. The psychologist also read the medical charts to check the
Argus figures for any involuntary admissions or coercive measures in the past five years.
Analyses
As appropriate, chi-square statistics or a Student’s t-test were used to test the differences
between three groups: not assessed with the SCIL, SCIL-positive, and SCIL-negative. Similarly,
for all patients, SCIL positive or otherwise, odds ratios were calculated for 1.) patient character-
istics, 2.) admission history, and 3.) having experienced coercive measures (as measured on
the Argus rating scale [17]) during the current hospital stay or during hospital stays in the pre-
vious five years. The significance level for the analyses was set at an α of 0.05. The analyses
were performed with SPSS version 20.
Results
Demographic and psychiatric characteristics
In the 12-month inclusion period, 314 patients were admitted for longer than 6 days, 208 of
whom (66.2%) could be examined using the SCIL. In 106 patients it was not possible to admin-
ister the SCIL, mostly because patients were discharged before the assessment could be com-
pleted (N = 49), but also because they had an insufficient command of Dutch (n = 20), refused
to participate (n = 6), or because very severe psychiatric symptoms were revealed during the
test (n = 2). 29 patients were not assessed because staff had no time to gather data. Table 1 con-
trasts the patient characteristics of three groups of patients: those for whom it was not possible
to obtain a score on the SCIL, those with a positive SCIL, and those with a negative SCIL.
Ninety-one patients of the 208 patients who were screened with the SCIL (43.8%) were
found to be SCIL positive. A higher number of patients in the SCIL-positive group than in the
SCIL-negative group (OR 0.53 SD 0.30–0.93) had no partner. Fewer were diagnosed with
depression (OR 0.50 SD 0.28–0.89). As may be expected, developmental disorders were more
common in the SCIL-positive patients(OR 3.73 SD 1.27–0.89).
After comparing patients with no SCIL, the non-responders with those who were SCIL
positive and those who were SCIL negative, the responders, we found that non-responders
contained significantly more patients in three groups: those of non-Western descent (chi-
square = 7.84, p = 0.02), those with drug-abuse disorder (chi-square = 5.56, p = 0.02), and
those with schizophrenia (chi-square = 5.51, p = 0.02). It is likely that the options for assessing
these patients had been impaired by language and attention problems.
The medical charts showed earlier documentation of an intellectual impairment in only a
minority of the 91 SCIL-positive patients (22.1%). Even though IQ was documented in only a
small number of patients, the mean IQ in the SCIL-positive group (n = 13) was 69, compared
to 89 (n = 11) in the SCIL-negative group.
Coercive measures. With respect to coercive experiences, SCIL-positive patients had a
higher risk of being admitted involuntarily (OR 2.71; SD 1.28–5.70, p<0.05). Their medical charts
also reported a higher number of past involuntary admissions (OR 2.20, SD 1.12–4.32, p<0.01),
and showed that patients who tested SCIL positive had had a higher risk of undergoing coercive
measures (i.e., seclusion, restraint and forced medication) (OR 3.95, SD 1.47–10.54, p<0.01).
Table 2 presents the outcomes for a number of coercion-related items in all SCIL groups.
Discussion
Approximately 40% of recently admitted psychiatric patients were at risk for having MID/BIF
as assessed on the SCIL. Only in 22.1% of the SCIL-positive group did the medical charts show
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Table 1. Comparisons between patients with no SCIL, SCIL-negative patients, and SCIL-positive patients.
No SCIL SCIL
negative
SCIL
positive
SCIL positive /
SCIL negative
Difference between all
groups
Difference between SCIL-positive and
SCIL-negative patients
OR 95% CI
OR
N = 106
(33.8%)
117(56.3%) 91 (43.8%)
Age 43.08 43.95 44.45 - -
Male 49.1% 41.0% 37.4%
Female 50.9% 59.0% 62.6% 1.16 0.66–
2.04
- -
No partner 64.2% 53.0% 68.1% - +
Partner 35.8% 47.0% 31.9% 0.53 0.30–
0.93
- +
Western descent 83.0% 96.6% 93.4%
Non-western descent 11.3% 2.6% 6.6% 0.37 0.09–
1.54
++ -
Unknown 5.7% 0.9% 0%
Diagnosis
No diagnosis* 4.8% 8.5% 12.1% 1.47 0.59–
3.63
++ -
Anxiety disorder 5.8% 9.4% 8.8% 0.93 0.36–
2.41
- -
Depression 24.0% 44.4% 28.6% 0.50 0.28–
0.89
++ +
Bipolar disorder 8.7% 8.5% 17.6% 2.28 0.98–
5.34
- -
Psychotic disorders 27.9% 16.2% 20.9% 1.36 0.67–
2.75
- -
Schizophrenia 11.5% 4.3% 4.4% 1.03 0.27–
3.95
+ -
Drug-abuse disorder 17.3% 8.5% 7.7% 0.89 0.33–
2.41
+ -
Personality disorder** 33.3% 26.5% 33.3% 1.36 0.75–
2.48
- -
Developmental disorder 11.4% 4.3% 14.3% 3.73 1.27–
10.89
- +
IQ data in charts 11.3% 11.8% 22.1% 2.12 0.98–
4.57
- -
Total IQ (score and n
=)
86 (5) 89 (11) 69 (13)
Performal IQ (n =) 83 (2) 101 (4) 86 (3)
Verbal IQ (n =) 83 (2) 98 (4) 87 (4)
WAIS (n =) 83 (4) 89 (9) 74 (11)
Visual WAIS (n =) 83 (4) 87 (9) 70 (11)
Working Memory Wais
(n =)
83 (4) 93 (9) 64 (11)
Processing speed
Wais (n =)
83 (4) 81 (9) 62 (11)
*: No diagnosis was found in the medical chart.
**: any personality disorder present.
OR = odds ratio— = no significant difference, + = significant difference, p<0.05, ++ = significant difference, p<0.01.
doi:10.1371/journal.pone.0168847.t001
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an earlier diagnosis of MID/BIF. A SCIL-positive patient was more likely than a SCIL-negative
one not to have a partner, and not to have been diagnosed with depression. SCIL-positive
patients were more likely to have been admitted involuntarily and to have been subjected to
coercive measures in the past.
If, as we assume, SCIL-positive patients are at a high risk of having MID/BIF, the prevalence
of MID/BIF is much higher in the current study than in the general population. The preva-
lence of MID/BIF in our patients was comparable to that in an unpublished study on patients
treated in Assertive Community Treatment teams, which found a prevalence of MID/BIF as
high as 59%. The study in question had assessed MID/BIF using a Dutch Intelligence Test
(GIT) [18]. Another study in ACT teams in Ontario, Canada, estimated MID to be 9–11%
[19]. We found no other studies that had assessed both MID and BIF in psychiatric patients.
Our finding that fewer SCIL-positive patients than SCIL-negative patients had a depressive
disorder contrasts with a study showing that affective disorder is one of the commonest disor-
ders in people with MID [8]. As we also know from the Diagnostic Manual—Intellectual Dis-
ability (DM-ID) [20] there may be differences between the clinical presentation of symptoms
in patients without intellectual problems and the presentation in the patients with MID (and
often BIF) we know in clinical practice. When depressed, adults with MID have been noted to
have higher rates of conduct problems, social withdrawal and irritable mood [8]. In the same
study, developmental disorder was diagnosed in 11.4% of the SCIL-positive group, against
4.5% in the negative group. These findings are confirmed in studies by Prasher et al [21] in
which an Autism Spectrum Disorder was associated with MID. In our SCIL-positive sample,
we note the modest number of patients diagnosed with substance-use disorder (SUD). A study
across several samples by Duijvenbode et al [22] showed that the prevalence of SUD with
MID/BIF varied very widely (0.5–21% or more).
Our results also show that, in the past, SCIL-positive patients had had more involuntary
admissions than SCIL-negative ones, and had experienced more coercive measures. This is a
remarkable finding. Coercive measures may obstruct recovery and even result in iatrogenic
PTSD [23]. People with MID/BIF have reduced coping skills, and easily react with verbal
Table 2. Use of coercive measures in patients with no SCIL, in SCIL-negative patients, and in SCIL-positive patients.
No SCIL SCIL
negative
SCIL
positive
SCIL positive /
SCIL negative
Difference between all
groups
Difference between SCIL-positive and
SCIL-negative patients
OR 95% CI
OR
106
(33.8%)
117 (56.3%) 91 (43.8%)
Currently involuntary
admitted
20.8% 11.1% 25.3% 2.71 1.28–
5.70
+ +
Admitted involuntarily in
last 5 years
35.8% 15.4% 28.6% 2.20 1.12–
4.32
++ +
Coercion* during current
stay
4.7% 3.4% 7.7% 2.35 0.67–
8.30
- -
Coercion* in the last 5
years
19.8% 5.1% 17.6% 3.95 1.47–
10.54
++ ++
Ever admitted
involuntarily
40.6% 23.1% 37.4% 1.99 1.08–
3.63
+ +
Ever experienced
coercion*
22.6% 7.7% 23.1% 3.60 1.56–
8.31
++ ++
*: coercion = seclusion, restraint and forced medication.
OR = odds ratio— = no significant difference, + = significant difference, p<0.05, ++ = significant difference, p<0.01.
doi:10.1371/journal.pone.0168847.t002
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aggression, and, in circumstances they cannot oversee, with abject behavior or refusal behav-
ior. In the context of an admission ward with large numbers of severely disordered patients,
their inability to cope may even increase, impairing diagnosis and the identification of treat-
ment that will meet their needs. To prevent coercion, MID/BIF patients treatment should thus
be adapted to their intellectual capacities and to their ability to understand their environment.
Strengths and limitations
Strengths. To our knowledge, this is the first prevalence study on MID/BIF in a relatively
large sample of acutely admitted psychiatric patients. Even though the assessments were per-
formed on acute psychiatric wards, we were able to include a substantial number of patients
(66.2%). In such a setting, this is a very reasonable response rate[24]. As the data were gathered
in two psychiatric wards in general hospitals, our findings have validity for clinical practice.
Because there were no specific selection criteria for admission to these wards, these findings
may be a good overall reflection of psychiatric patients admitted in the Netherlands.
Limitations. The first limitation is that the SCIL is a screener instrument for assessing
MID/BIF that was not followed by a fully validated IQ test, such as the WAIS, and then—as
might be preferred—by a second test for emotional and adaptive functioning.
The second limitation is that we do not know what causes a SCIL-positive result: it may
result from cognitive decline, from psychiatric disease or symptoms, or from long-term psy-
chiatric medication. Nevertheless, whatever the origin of the intellectual impairment, our
study shows that a high proportion of patients who are admitted in the acute phase of psychiat-
ric disease appear to function at the level of MID/BIF, and that their treatment and handling
should be adapted to their specific abilities and care needs. To what extent the intellectual
impairment with which they present is an inborn defect or the effect of cognitive decline or is
a subject for further research.
A third possible limitation is that there may have been a selection bias involving patients
with schizophrenia, drug abuse and those of non-western descent.
Finally, no structured interview was used to establish the DSM-IV–TR diagnosis.
Recommendations for clinical practice and research. To assess their earlier intellectual
aptitude, we recommend that all patients admitted are interviewed with regard to their school
career, diplomas, and employment. To understand the impairments of a patient with MID/
BIF, clinicians have to adapt their communication and attitude. This can help to avoid coer-
cion, and can also support the recovery process.
Although the SCIL is not a cognitive test in the narrower sense, and although many skills
required to perform the small tasks in the SCIL are learned in early life, we do not yet know
the influence of psychiatric symptoms on the SCIL test result. We therefore recommend fur-
ther research on the association between SCIL findings, psychiatric symptoms, medication,
and drug use or drug abuse that possibly results in cognitive decline. As well as examining
intellectual capacities with an intelligence test, one might consider other assessments of adap-
tive functioning and social emotional development. Finally, we recommend that the current
study is repeated in first referral patients, Functional Assertive Community Treatment (FACT)
patients, and long-stay patients.
Conclusions
Overall, we feel it is fair to assume on the basis of our results that MID/BIF is present in a sub-
stantial proportion of admitted psychiatric patients, and that such a diagnosis may often be
overlooked in the acute phase of psychiatric disease. Findings show a relatively high number of
patients with a suspected MID/BIF, next to a substantial lack of information on education and
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employment history in their biographies. To assess their earlier intellectual aptitude, we rec-
ommend that all patients referred to mental health treatment are interviewed with regard to
their school career, diplomas, and employment. To understand the impairments of a patient
with MID/BIF, clinicians have to adapt their communication and attitude. This may provide
an impression of formal intellectual functioning, can help to avoid coercion, and can also sup-
port the recovery process.
It is also important to gain an impression of a patient’s intellectual capacities—by using the
SCIL, for example—and of their social function skills and adaptive behavior. Examination of
the patient’s intellectual capacities through an intelligence test might also be considered. Fail-
ure to identify an MID/BIF may represent an additional risk with regard not only to involun-
tary admission, but also the use of coercive measures that may lead to iatrogenic damage. The
need to identify this particular patient group at an earlier point in treatment is an important
challenge in mental healthcare.
Supporting Information
S1 Data. The file scildataplosone.zip contains the underlying data for data sharing pur-
poses. The first line of the database formatted in Excel contains the variable labels. Please con-
tact the second author on e.noorthoorn@ggnet.nl when data are pooled.
(ZIP)
Acknowledgments and ethical considerations
Medical Ethical approval for the study was provided in 2014 by the ethical board of the Univer-
sity of Twente, Enschede, the Netherlands. All procedures performed in the current study
were in accordance with the 1964 Helsinki declaration and its later amendments; and with
comparable ethical standards. Data were analysed on the basis of fully anonymized data that
allowed none of the cases to be traced to an individual. Data for sharing findings (S1 Data)
may be requested by contacting the second author at E.noorthoorn@ggnet.nl.
Author Contributions
Conceptualization: JGN EON CLM PN HLIN.
Data curation: JGN EON.
Formal analysis: JGN EON CLM PN HLIN.
Funding acquisition: JGN.
Investigation: JGN EON.
Methodology: JGN EON CLM PN HLIN.
Project administration: EON.
Resources: JGN EON HLIN.
Software: JGN EON.
Supervision: CLM.
Validation: JGN EON CLM PN HLIN.
Writing – original draft: JGN EON PN HLIN CLM.
A Blind Spot? Screening Mild or Borderline Intellectual Disability or Functioning in Psychiatry
PLOS ONE | DOI:10.1371/journal.pone.0168847 February 2, 2017 8 / 10
Writing – review & editing: JGN EON PN HLIN CLM.
References
1. Snell ME, Luckasson R, Borthwick-Duffy WS, Bradley V, Buntinx WH, Coulter DL, et al. (2009) Charac-
teristics and needs of people with intellectual disability who have higher IQs. Intellectual Developmental
Disability. Jun; 47(3):220–33.
2. Verstegen D & Moonen X (2010) Van debilitas mentis naar licht verstandelijke berperking [From debili-
tas mentis to a Mild Intellectual Disability]. Onderzoek en praktijk, 8, 2, 8–16.
3. Fernell E & Ek U (2010) Borderline intellectual functioning in children and adolescents—insufficiently
recognized difficulties. Acta Pediatrica. May; 99(5):748–53.
4. Gigi K, Goldberg S, Portuguese S, Reichenberg A, Fruchter E, Weiser M. (2014) Borderline intellectual
functioning is associated with poor social functioning, increased rates of psychiatric diagnosis and drug
use–A cross sectional population based study. European Neuropsychopharmacology, Nov; 24
(11):1793–7. doi: 10.1016/j.euroneuro.2014.07.016 PMID: 25224107
5. Wullink M, Schrojenstein HMJ, Dinant GJ, Metsemakers JFM (2007) Prevalence of people with intellec-
tual disability in the Netherlands. Journal of Intellectual Disability Research, 51, (7) 511–519.
6. Westerinen H, Kaski M, Virta L, Almqvist F and Iivanainen M(2007) Prevalence of intellectual disability:
a comprehensive study based on national registers. Journal of Intellectual Disability Research, 51 (9),
715–725
7. Morgan VA, Leonard H, Bourke J, Jablensky A (2008) Intellectual disability co-occurring with schizo-
phrenia and other psychiatric illness: population-based study. British Journal of Psychiatry, Nov; 193
(5):364–72. doi: 10.1192/bjp.bp.107.044461 PMID: 18978313
8. Hurley AD (2006) Mood disorders in intellectual disability. Current opinion psychiatry 19: 465–469.
9. Tyrer P, Hassiotis A, Ukoumunne O, Piachaud J Harvey K (1999) Intensive case management for psy-
chotic patients with borderline intelligence. UK 700 Group. Lancet. Sep 18; 354 (9183):999–1000.
PMID: 10501366
10. Pogge DL, Stokes J, Buccolo ML, Pappalardo S, Harvey PD. Discovery of previously undetected intel-
lectual disability by psychological assessment: a study of consecutively referred child and adolescent
psychiatric inpatients.Discovery of previously undetected intellectual disability by psychological assess-
ment: a study of consecutively referred child and adolescent psychiatric inpatients.Discovery of previ-
ously undetected intellectual disability by psychological assessment: a study of consecutively referred
child and adolescent psychiatric inpatients.Discovery of previously undetected intellectual disability by
psychological assessment: a study of consecutively referred child and adolescent psychiatric inpatients.
Res Dev Disabil. 2014 Jul; 35(7):1705–10.Research Developmental Disabilities. 2014 Jul;35(7):1705–
10. doi: 10.1016/j.ridd.2014.03.012 PMID: 24679700
11. Neijmeijer L, Moerdijk L, Veneberg G & Muusse C (2010) Licht Verstandelijk Gehandicapten in de
GGZ, een verkennend onderzoek. [Mild and Borderline intellectual disability in Mental health care, an
exploratory study] Trimbos-instituut, Utrecht.
12. Cooper SA & Simpson N (2006) Assessment and classification of psychiatric disorders in adults with
learning disabilities Psychiatry. 5: 9, 306–311.
13. Elm von E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. (2007) The strengthen-
ing the Reporting of Observational Studies in Epidemiology (STROBE) statement. Guidelines for report-
ing observational studies. Epidemiology, 18: 800–804. doi: 10.1097/EDE.0b013e3181577654 PMID:
18049194
14. Kaal HL, Nijman HLI, Moonen XMH. SCIL: Screener Intelligence Learning Disabilities. Hogrefe uitg-
evers weteringschans 128 1017 Amsterdam.
15. Kaal HL, Nijman HLI, Moonen XMH (2015) Identifying offenders with an intellectual disability in deten-
tion in The Netherlands. Journal of Intellectual Disabilities and Offending Behavior, 6, 2, 94–101
16. Nijman H., Kaal H, van Scheppingen L. & Moonen X. (in press). Development and testing of a Screener
for intelligence and learning disabilities (SCIL). Journal of Applied Research in Intellectual Disabilities.
17. Janssen WA, van de Sande R, Noorthoorn EO, Nijman HLI, Bowers L, Mulder CL, et al. (2011) Method-
ological issues in monitoring the use of restrictive measures. International Journal of Law and Psychia-
try. 34: 429–438. doi: 10.1016/j.ijlp.2011.10.008 PMID: 22079087
18. Stuurman S, Mulder A, van Straaten B, Kruijt P, de Baan M, Mulder N (2008) Intelligentieonderzoek bij
patie¨nten van assertive community treatment (ACT)-teams [A study into intelligence of patients of
Assertive Community Treatment (ACT)—teams]. Rotterdam (NL) Bavo Europoort.
19. Burge P (2006) Assertive Community Treatment Teams and Adults with Intellectual Disabilities. Journal
of Developmental Disabilities., 15, 3, 96–102.
A Blind Spot? Screening Mild or Borderline Intellectual Disability or Functioning in Psychiatry
PLOS ONE | DOI:10.1371/journal.pone.0168847 February 2, 2017 9 / 10
20. Fletcher RJ, Loschen E, Stavrakaki C, First M (eds) (2007) Diagnostic manual—intellectual disability: a
textbook of diagnosis of mental disorders in persons with intellectual disability. New York (NY): The
National Association for the Dually Diagnosed.
21. Prasher VP, Kapadia HM (2006) Epidemiology of learning disability and comorbid conditions, Psychia-
try 5:9, 3002–3005.
22. Duijvenbode N van, VanDerNagel JE, Didden R, Engels RC, Buitelaar JK, Kiewik M et al (2015). Sub-
stance use disorders in individuals with mild to borderline intellectual disability: current status and future
directions. Research Developmental Disability, Mar; 38:319–28.
23. Muskett C (2014) Trauma informed care in inpatient mental health settings: a review of literature. Inter-
national journal of mental health nursing. 23 (1) 51–59. doi: 10.1111/inm.12012 PMID: 23363398
24. Bowers L, James K, Quirk A, Simpson A, Stewart D, Hodsoll J (2015) Reducing conflict and contain-
ment rates on acute psychiatric wards: The Safewards cluster randomized controlled trial. International
Journal of Nursing Studies. Sep; 52(9):1412 doi: 10.1016/j.ijnurstu.2015.05.001 PMID: 26166187
A Blind Spot? Screening Mild or Borderline Intellectual Disability or Functioning in Psychiatry
PLOS ONE | DOI:10.1371/journal.pone.0168847 February 2, 2017 10 / 10
